These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2824950)

  • 1. High affinity peptide histidine isoleucine-preferring receptors in rat liver.
    Paul S; Chou J; Kubota E
    Life Sci; 1987 Nov; 41(21):2373-80. PubMed ID: 2824950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHI preferentially binds to VIP receptors in normal rat tissues.
    Huang M; Rorstad OP
    Peptides; 1990; 11(5):1015-20. PubMed ID: 2178244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
    Guijarro L; Couvineau A; Calvo JR; Laburthe M
    Regul Pept; 1989 Apr; 25(1):37-50. PubMed ID: 2541470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
    Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S; Said SI
    J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M; Carlquist M; Maletti M; Marie JC
    FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that vascular actions of PHI are mediated by a VIP-preferring receptor.
    Huang M; Itoh H; Lederis K; Rorstad O
    Peptides; 1989; 10(5):993-1001. PubMed ID: 2558369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells.
    Chijiiwa Y; Murthy KS; Grider JR; Makhlouf GM
    Regul Pept; 1993 Sep; 47(3):223-32. PubMed ID: 8234906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S; Veliçelebi G
    Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
    Patthi S; Simerson S; Veliçelebi G
    J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
    Nguyen TT; Krco CJ; Gores A; Go VL
    Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
    Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.